Pan resistant Acinetobacter baumanii in a tertiary care hospital

SEARCH WITHIN CONTENT

Online First

Sreekanth Basireddy, Salmaan Ali, Manisha Singh, Vasanti Kabra

Citation Information : Basireddy S, Ali S, Singh M, Kabra V. Pan resistant Acinetobacter baumanii in a tertiary care hospital. 2015; 17 (1):58-59.

DOI: 10.4103/0972-1282.158813

License: CC BY-NC-SA 4.0

Published Online: 15-07-2024

PDF Share

Taneja N, Singh G, Singh M, Sharma M. Emergence of Tigecycline & Colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in North India. Indian J Med Res 2011;133:681-4.
Najotra DK, Slathia P, Kumar N, Digra SK. The in vitro activity of Tigecycline against the multidrug resistant Acinetobacter spp. at a tertiary care hospital. J Clin Diagn Res 2012;6:1184-7.
Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella and other nonfermentative Gram-negative rods. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of Clinical Microbiology. Vol. 9. Washington, DC: ASM Press; 2007. p. 770-802.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twenty-third informational supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2013. p. 66-7.
Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. Multicenter studies of Tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007;45:227-30.

PDF Share